Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Key Account Manager

Account ManagementConfirmed live in the last 24 hours

Full-timeBarcelona, SpainNo salary listed

About the Job

Requirements

A university degree in a business-related field such as health or business management, or a comparable educational background.
At least five years of experience in specialty care and/or Key Account Management in bio/pharmaceutical sales.
Strong business acumen and strategic thinking to add value to existing healthcare structures.
Ability to gain consistent access to healthcare providers in reference centers and the community, and develop strong professional relationships for product promotion.
Ability to communicate effectively and influence professionals at all organizational levels.
Ability to use previous experiences and insights to generate and maintain appropriate awareness and timely access to treatment.
Ability to communicate and lead cross-functionally with other field-based functions.
Excellent organizational and project-management skills.
Ability to travel regularly within a territory, including overnight travel, and hold a valid driver's license.

Responsibilities

Develop and implement territory-specific strategic account plans aligned with overall product strategy and in close alignment with Medical Affairs, Marketing, and Market Access, while complying with company, industry, legal, regulatory, and ethical standards.
Present a positive image of the company and build awareness of the RNA interference platform among relevant customer groups.
Develop, own, and drive territory and account plans, including customer targeting, in line with country strategy and in partnership with Marketing and Medical Affairs.
Achieve post-launch key performance indicators, including sales and volume targets.
Use advanced sales skills to ensure consistent and continuous messaging.
Analyze the assigned territory to identify, assess, and develop relevant centers for diagnosis and treatment.
Drive patient-group identification, diagnosis, and referral rates through strategic intersectoral referral-network management in close cooperation with other field-based functions.
Develop trusted relationships with a portfolio of customers and build a thorough understanding of their needs and requirements to ensure market penetration.
Coordinate with internal stakeholders, including commercial, supply chain, and compliance teams, and external centers to ensure products and services are delivered to customers in a timely manner.
Establish and maintain contact with key customers; provide commercial and scientific services to ensure access at the site of care and that product-administration logistics are in place.
Manage and execute local meetings with the Medical Affairs team for physicians and other healthcare professionals to drive diagnosis and treatment rates.
Represent the company at local and national events and congresses.
Serve as the communication link between key customers and internal teams.
Collaborate with internal staff, including Medical Affairs, Sales, Marketing, Market Access, and Business Operations, as required.
Lead regular local alignment meetings with other field-based functions to support implementation of territory and account plans and achieve their intended outcomes.
Report accurately and on time, and maintain the customer relationship management database.
Conduct all activities according to high ethical standards and applicable country codes of practice and local laws and regulations.
Travel domestically and occasionally internationally as needed.

Desired Qualifications

Cardiology knowledge is preferable.
Fluency in written and spoken English is desirable.

Overview

The Key Account Manager (KAM) is a field-based expert that strategically drives the commercial objectives of selected Alnylam products for Spain in the assigned territory. The KAM, reporting to area sales lead, is expected to develop and implement key account plans and works in close cross functional collaboration with other field-based functions to optimize the intersectoral patients care in the designated territory.

The Key Account Manager is expected to develop territory specific strategic account plans in the context of the overall product strategy and in close alignment with functions of Medical Affairs, Marketing and Market Access, while ensuring full compliance with all relevant company, industry, legal, regulatory and ethical standards.

Summary of Key Responsibilities

Presents a positive image of the company and develop awareness about RNAi platform to relevant customer groups.
Develops, own and drives territory and account plan, including customer targeting, in line with country strategy in partnership with Marketing and Medical Affairs team.
Achieves post-launch KPIs, including sales and volume targets.
Use advanced sales skills to ensure consistent and continuous messaging.
Performs detailed analysis of the assigned territory to identify, assess, and develop relevant centers for diagnosis and treatment.
Drives patient group identification, diagnosis and referral rates by strategic intersectoral referral network management in close cooperation with other field-based functions.
Develop trusted relationships with a portfolio of customers to ensure market penetration, after developing a thorough understanding of key customer needs and requirements
Ensures the correct products and services are delivered to customers in a timely manner by collaborating with internal stakeholders (commercial, supply chain, and compliance) and external centers.
Establish and maintain contact with key customers and provide commercial and scientific services to ensure access at site of care, and that logistics are in place to administer product
Manages and executes local meetings to drive diagnosis and treatment rates, in collaboration with the Medical Affairs Team for physicians and other healthcare professionals
Represents Alnylam at local and national events and congresses
Serves as the link of communication between key customers and internal teams
Liaises and collaborates with relevant internal staff (Medical Affairs, Sales Manager, Brand Manager, Market Access, and Business Operations Manager), as required.
Steers regular local alignment meetings with other field-based functions to ensure proper implementation and outcomes against the committed territory and account plans.
Timely and accurate reporting and continuous diligent maintenance of the CRM database
Conducts all activities to highest ethical standards in accordance with country code of practice and local Laws and regulations
Significant domestic travel and occasional international travel as needed

Qualifications

University degree in a business-related field such as health or business management or comparable educational background
+5 years of experience in specialty care and/or Key Account Management experience in bio/pharmaceutical sales, cardiology knowledge preferable
Strong business acumen/strategic thinking to add value to the existing health care structures.
Ability to gain consistent access and develop strong & professional relationships for product promotion with healthcare providers in reference centers and the community
Effective communication and influencing skills to engage with professionals at all organizational levels
Ability to draw on previous experiences and insights to generate and maintain appropriate awareness and timely access to treatment
Ability to communicate and lead cross-functional with other field-based functions
Excellent organizational/project-management skills
Ability to travel within a territory on a regular basis including overnight, and must hold a valid driver's license
Fluent in English written and oral is desire.

#LI-LR1 #REMOTE

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.

Before applying, please review Alnylam's ⁠Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size: 1,001-5,000
Company stage: IPO
Headquarters: Cambridge, MA
Founded: 2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs